BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$301.92 USD
+5.10 (1.72%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $302.11 +0.19 (0.06%) 7:56 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Bio-Rad Laboratories, Inc. [BIO]
Reports for Purchase
Showing records 141 - 145 ( 145 total )
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Medical Technology: Thoughts on Our Medical Technology Universe Heading Into the Dog Days of Summer
Provider: COLLIERS SECURITIES
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
BIO: Slow Start to CY12, Margin Pressure Could Continue in CY13, Fully Valued at These Levels Downgrading to NEUTRAL
Provider: COLLIERS SECURITIES
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
BIO: We Like This Stable Clinical Diagnostics & Life Science Tools Company Initiating Coverage of Bio Rad Laboratories (BIO) with a BUY Rating
Provider: COLLIERS SECURITIES
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
1Q 2011 Earnings
Provider: G.RESEARCH, LLC
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Diagnostics - Buy
Provider: G.RESEARCH, LLC